Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENAVO-AF
NCT06528262Phase 4Recruiting
- Sponsor
- Yonsei University
- Start
- Apr 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of enavogliflozin in Atrial fibrillation (AFib), sponsored by Yonsei University. Started Apr 2025; status: recruiting.
02
Drugs
enavogliflozin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06528262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06528262.